Chinese biotech company gets go-ahead for mRNA COVID-19 omicron trial in the Philippines
Jiangsu Recbio Technology Co., Ltd. has received clinical trial approval for R520A, a mRNA COVID-19…
27/06/2022 - 1 minute
Jiangsu Recbio Technology Co., Ltd. has received clinical trial approval for R520A, a mRNA COVID-19…
Specialty vaccine company, Valneva, has been given marketing authorization in Europe for its inactivated whole-virus…
Researchers at Rensselaer Polytechnic Institute in Troy, NY, have developed N95 surgical face masks that…
Therorna Inc., a Chinese biotech company specializing in the development of circular RNA (circRNA) technology-based…
A year after the creation of the mRNA Vaccine Technology Transfer Hub, two biotech companies…